Drugs in Dev.
Infections and Infectious Diseases
Discovery Platform
Japan 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Fujitsu
Deal Size : Undisclosed
Deal Type : Merger
Japan's Fujitsu, Mizuho, PeptiDream to Establish Joint Venture to Develop COVID-19 Treatments
Details : The new company, to be called PeptiAID Inc, will research and develop peptide therapeutics for the current SARS-CoV-2 virus and potential future coronavirus outbreaks.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
November 12, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Fujitsu
Deal Size : Undisclosed
Deal Type : Merger
